Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.
Leborgne C, Barbon E, Alexander JM, Hanby H, Delignat S, Cohen DM, Collaud F, Muraleetharan S, Lupo D, Silverberg J, Huang K, van Wittengerghe L, Marolleau B, Miranda A, Fabiano A, Daventure V, Beck H, Anguela XM, Ronzitti G, Armour SM, Lacroix-Desmazes S, Mingozzi F. Leborgne C, et al. Among authors: daventure v. Nat Med. 2020 Jul;26(7):1096-1101. doi: 10.1038/s41591-020-0911-7. Epub 2020 Jun 1. Nat Med. 2020. PMID: 32483358 Free article.
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy.
Mimoun A, Bou-Jaoudeh M, Delignat S, Daventure V, Reyes Ruiz A, Lecerf M, Azam A, Noe R, Peyron I, Christophe OD, Lenting PJ, Proulle V, McIntosh J, Nathwani AC, Dimitrov JD, Denis CV, Lacroix-Desmazes S. Mimoun A, et al. Among authors: daventure v. J Thromb Haemost. 2023 Sep;21(9):2405-2417. doi: 10.1016/j.jtha.2023.05.021. Epub 2023 Jun 2. J Thromb Haemost. 2023. PMID: 37271431
Aromatic Guanylhydrazones for the Control of Heme-Induced Antibody Polyreactivity.
Božinović N, Ajdačić V, Lazic J, Lecerf M, Daventure V, Nikodinovic-Runic J, Opsenica IM, Dimitrov JD. Božinović N, et al. Among authors: daventure v. ACS Omega. 2019 Nov 22;4(24):20450-20458. doi: 10.1021/acsomega.9b01548. eCollection 2019 Dec 10. ACS Omega. 2019. PMID: 31858028 Free PMC article.
High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitro.
Sekar R, Mimoun A, Bou-Jaoudeh M, Loyau S, Delignat S, Daventure V, Bonilla P, Bhale AS, Venkataraman K, Rayes J, Boulaftali Y, Jandrot-Perrus M, Proulle V, Lacroix-Desmazes S. Sekar R, et al. Among authors: daventure v. J Thromb Haemost. 2024 May;22(5):1489-1495. doi: 10.1016/j.jtha.2024.01.021. Epub 2024 Feb 5. J Thromb Haemost. 2024. PMID: 38325597 Free article.
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.
Bou-Jaoudeh M, Mimoun A, Delignat S, Peyron I, Capdevila L, Daventure V, Deligne C, Dimitrov JD, Christophe OD, Denis CV, Lenting PJ, Proulle V, Lacroix-Desmazes S. Bou-Jaoudeh M, et al. Among authors: daventure v. J Thromb Haemost. 2023 Oct;21(10):2776-2783. doi: 10.1016/j.jtha.2023.06.038. Epub 2023 Jul 18. J Thromb Haemost. 2023. PMID: 37473843 Free article.